Back

Haemodynamic implications of mitral regurgitation in heart failure with preserved ejection fraction

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Novelties in pathophysiology of heart failure with preserved ejection fraction Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Maria Amalia Tamargo Delpon

University Hospital of Salamanca, Salamanca (Spain)

6 More presentations in this session

Presentation thumbnail
Heart failure with mid-range (HFmrEF) or recovered (HFrecEF) ejection fraction: differential determinants of transition
Doctor A. Mortara (Monza, IT)
Abstract Slides
Presentation thumbnail
A single factor related to left atrial pressure overload is useful for prognosis in elderly patients with heart failure with preserved ejection fraction: PURSUIT HFpEF study
Doctor S. Hoshida (Yao, JP)
Abstract Slides
Presentation thumbnail
Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen
Doctor O. Medentseva (Kharkiv, UA)
Abstract Slides
Presentation thumbnail
Impact of impaired right ventricular strain on the prognosis of HFpEF.
Doctor S. Lejeune (Brussels, BE)
Abstract Slides
Presentation thumbnail
Incremental value of left atrial strain in predicting atrial fibrillation in heart failure with preserved ejection fraction
Doctor E. Jasic-Szpak (Wroclaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Novelties in pathophysiology of heart failure with preserved ejection fraction

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources